SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-015920
Filing Date
2024-02-15
Accepted
2024-02-15 16:25:31
Documents
65
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K mnov-20231231.htm   iXBRL 10-K 1867947
2 EX-19.1 mnov-ex19_1.htm EX-19.1 235073
3 EX-23.1 mnov-ex23_1.htm EX-23.1 4042
4 EX-31.1 mnov-ex31_1.htm EX-31.1 11579
5 EX-31.2 mnov-ex31_2.htm EX-31.2 11508
6 EX-32.1 mnov-ex32_1.htm EX-32.1 8990
7 EX-32.2 mnov-ex32_2.htm EX-32.2 9322
8 EX-97.1 mnov-ex97_1.htm EX-97.1 48345
  Complete submission text file 0000950170-24-015920.txt   7114589

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mnov-20231231.xsd EX-101.SCH 877239
67 EXTRACTED XBRL INSTANCE DOCUMENT mnov-20231231_htm.xml XML 1028349
Mailing Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

IRS No.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33185 | Film No.: 24644193
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)